ACIMAB — 2121983
Application number
2121983
Registration number
TMA1301783
Type(s)
Standard Characters
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2021-07-21
Registered
2025-03-26
Registration Expiry Date
2035-03-26
Registered Owner
TEVA Pharmaceutical Industries Limited
124 Dvora HaNevi'a
6944020 Tel Aviv-Jaffa
ISRAEL
Agent
OSLER, HOSKIN & HARCOURT LLP
Suite 320, World Exchange Plaza
100 Queen Street
Ottawa,
ONTARIO K1P1J9
Documents
Index headings
- ACIMAB
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical preparations for the treatment of Multiple Sclerosis, Lupus Nephritis and Crohn's Disease.
Recordals (known also as Footnotes)
Owner Address Change / Changement d'adresse du propriétaire DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2022-02-28 COMMENTS / COMMENTAIRES: Voir Preuve au dossier/See evidence on File No. 2121983Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2021-07-21 | ||
| Created | 2021-07-21 | ||
| Formalized | 2021-07-21 | ||
| Amendment to Application | 2022-02-28 | Owner Address Change / Voir Preuve au dossier/See evidence on File No. 2121983 | |
| Pre-Assessment Letter Sent | 2022-07-06 | Goods or Services Not Acceptable | |
| Search Recorded | 2024-12-06 | ||
| Approved | 2024-12-16 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2024-12-16 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2025-01-08 | Vol.72 Issue 3663 | |
| Registration Pending | 2025-03-26 | ||
| Registered | 2025-03-26 | 2035-03-26 |